Stemgenics

About:

Stemgenics is a developer of a technology that converts mature skin cells into personalized stem cells.

Website: http://stemgenics.com

Top Investors: National Science Foundation

Description:

Stemgenics is a developer of a technology that converts mature skin cells into personalized stem cells. The company's personalized stem cells may be used to regenerate any tissue of the human body. Stem cells can grow and develop into any cell type of the body. They are not rejected but are accepted by the body as its own cells. In Stemgenics' breakthrough process, cells from a small patch of skin are placed in cell culture. Its patent-pending functionalized nanoparticles are added and the skin cells are reprogrammed into stem cells.

Total Funding Amount:

$3.53M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2008-01-01

Founders:

Andranik Aprikyan, Frederick Hagen

Number of Employees:

1-10

Last Funding Date:

2018-06-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai